Insiders · DNA

Barry Canton

10% owner at Ginkgo Bioworks Holdings, Inc. (DNA) since September 2021

Barry Canton has filed 93 insider reports with the SEC since September 2021, as 10% owner at Ginkgo Bioworks Holdings, Inc. (DNA). In the last 12 months Barry Canton sold $978K of stock on the open market. The latest filing, on July 30, 2026, reports grant or award at Ginkgo Bioworks Holdings, Inc. (DNA).

Filings
93
Companies
1
Bought on market
None
Sold on market
$60.6M

Companies where Barry Canton is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
DNA Ginkgo Bioworks Holdings, Inc.10% ownersince September 2021338,568$60.6M$11.29Jul 30, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Barry Canton with

Other insiders at the same companies

Questions about Barry Canton

What is Barry Canton's role at Ginkgo Bioworks Holdings, Inc.?
Barry Canton reports to the SEC as 10% owner at Ginkgo Bioworks Holdings, Inc. (DNA), according to the latest filing on July 30, 2026.
How many shares does Barry Canton own?
After the latest filing that states it, Barry Canton directly owned 338,568 shares of Ginkgo Bioworks Holdings, Inc. (DNA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Barry Canton bought or sold stock recently?
The most recent open-market sale was on April 10, 2026: sold 124,727 shares of Ginkgo Bioworks Holdings, Inc. (DNA) for $802K at an average of $6.43.
How do I get alerts when Barry Canton files?
Follow Barry Canton on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Barry Canton (SEC CIK 0001882756). Totals count each trade once, skipping amendments whose original is on file, from Sep 21, 2021 on. View on SEC EDGAR